562 related articles for article (PubMed ID: 21830812)
1. Theranostics: combining imaging and therapy.
Kelkar SS; Reineke TM
Bioconjug Chem; 2011 Oct; 22(10):1879-903. PubMed ID: 21830812
[TBL] [Abstract][Full Text] [Related]
2. Inorganic nanoparticles for cancer imaging and therapy.
Huang HC; Barua S; Sharma G; Dey SK; Rege K
J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
[TBL] [Abstract][Full Text] [Related]
3. A review of NIR dyes in cancer targeting and imaging.
Luo S; Zhang E; Su Y; Cheng T; Shi C
Biomaterials; 2011 Oct; 32(29):7127-38. PubMed ID: 21724249
[TBL] [Abstract][Full Text] [Related]
4. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
Cheon J; Lee JH
Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
[TBL] [Abstract][Full Text] [Related]
5. Promising approaches in using magnetic nanoparticles in oncology.
Mikhaylov G; Vasiljeva O
Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
[TBL] [Abstract][Full Text] [Related]
6. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
Alberti C
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
[TBL] [Abstract][Full Text] [Related]
7. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
8. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
Höink AJ; Heindel W; Buerke B
Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
[TBL] [Abstract][Full Text] [Related]
9. Magnetic and fluorescent graphene for dual modal imaging and single light induced photothermal and photodynamic therapy of cancer cells.
Gollavelli G; Ling YC
Biomaterials; 2014 May; 35(15):4499-507. PubMed ID: 24602568
[TBL] [Abstract][Full Text] [Related]
10. Biomedical nanomaterials for imaging-guided cancer therapy.
Huang Y; He S; Cao W; Cai K; Liang XJ
Nanoscale; 2012 Oct; 4(20):6135-49. PubMed ID: 22929990
[TBL] [Abstract][Full Text] [Related]
11. 'Two is better than one'--probes for dual-modality molecular imaging.
Jennings LE; Long NJ
Chem Commun (Camb); 2009 Jun; (24):3511-24. PubMed ID: 19521594
[TBL] [Abstract][Full Text] [Related]
12. Combined PET/MRI: one step further in multimodality imaging.
Sauter AW; Wehrl HF; Kolb A; Judenhofer MS; Pichler BJ
Trends Mol Med; 2010 Nov; 16(11):508-15. PubMed ID: 20851684
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging: novel tools in visualizing rheumatoid arthritis.
Wunder A; Straub RH; Gay S; Funk J; Müller-Ladner U
Rheumatology (Oxford); 2005 Nov; 44(11):1341-9. PubMed ID: 15972356
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles for bioimaging.
Sharma P; Brown S; Walter G; Santra S; Moudgil B
Adv Colloid Interface Sci; 2006 Nov; 123-126():471-85. PubMed ID: 16890182
[TBL] [Abstract][Full Text] [Related]
15. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
[TBL] [Abstract][Full Text] [Related]
16. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.
Rappeport ED; Loft A
Abdom Imaging; 2007; 32(5):624-34. PubMed ID: 17710359
[TBL] [Abstract][Full Text] [Related]
17. Translational imaging of lymphatics in cancer.
Cohen SM; Fishinghawk BG; Cohen MS
Adv Drug Deliv Rev; 2011 Sep; 63(10-11):956-62. PubMed ID: 21683745
[TBL] [Abstract][Full Text] [Related]
18. The evolution of musculoskeletal tumor imaging.
Hwang S; Panicek DM
Radiol Clin North Am; 2009 May; 47(3):435-53. PubMed ID: 19361669
[TBL] [Abstract][Full Text] [Related]
19. Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.
Rhee JK; Park OK; Lee A; Yang DH; Park K
Mar Drugs; 2014 Dec; 12(12):6038-57. PubMed ID: 25522316
[TBL] [Abstract][Full Text] [Related]
20. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
